Your browser is no longer supported. Please, upgrade your browser.
BFRI [NASD]
Biofrontera Inc.
Index- P/E- EPS (ttm)-1.30 Insider Own69.00% Shs Outstand14.26M Perf Week-45.95%
Market Cap60.89M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float3.60M Perf Month12.96%
Income-10.40M PEG- EPS next Q- Inst Own- Short Float5.55% Perf Quarter-
Sales19.00M P/S3.20 EPS this Y0.00% Inst Trans- Short Ratio0.01 Perf Half Y-
Book/sh-0.17 P/B- EPS next Y- ROA- Target Price20.00 Perf Year-
Cash/sh0.13 P/C33.83 EPS next 5Y- ROE- 52W Range2.25 - 10.40 Perf YTD-3.17%
Dividend- P/FCF- EPS past 5Y- ROI-166.70% 52W High-59.13% Beta-
Dividend %- Quick Ratio0.40 Sales past 5Y- Gross Margin51.20% 52W Low88.88% ATR1.37
Employees56 Current Ratio0.90 Sales Q/Q143.80% Oper. Margin- RSI (14)- Volatility45.30% 23.84%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.40 Prev Close4.27
ShortableYes LT Debt/Eq- EarningsNov 30 BMO Payout- Avg Volume21.07M Price4.25
Recom- SMA208.40% SMA508.18% SMA2008.18% Volume4,753,462 Change-0.47%
Dec-06-21 09:00AM  
Dec-02-21 12:38PM  
09:15AM  
Dec-01-21 07:05PM  
Nov-30-21 09:20AM  
Nov-29-21 09:27AM  
Nov-24-21 10:45AM  
04:56AM  
Nov-23-21 08:15AM  
Nov-16-21 09:03AM  
Nov-02-21 02:45PM  
Oct-28-21 09:40PM  
Oct-14-21 06:31AM  
Biofrontera Inc., a biopharmaceutical company, develops and provides dermatological products for the treatment of skin diseases in the United States. It primarily develops therapies for non-melanoma skin cancer. It offers Ameluz, an aminolevulinic acid hydrochloride gel for the photodynamic therapy of actinic keratoses; and BF-RhodoLED, an LED lamp emitting red light for use in photodynamic therapy. The company was founded in 1997 and is based in Woburn, Massachusetts.